Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Fahima Danesh Pouya, Yousef Rasmi & Mohadeseh Nemati. (2022) Signaling Pathways Involved in 5-FU Drug Resistance in Cancer. Cancer Investigation 40:6, pages 516-543.
Read now
Read now
Muhammad Wasif Saif. (2020) Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity. OncoTargets and Therapy 13, pages 10197-10206.
Read now
Read now
Meng He, Jinghua Sun, Danyi Zhao, Hongmei He, Bing Wang, Lingling Xu, Yu Shang, Shanling Ren, Yang Zhang & Tao Wu. (2019) Modified-FOLFIRINOX combined with deep regional hyperthermia in pancreatic cancer: a retrospective study in Chinese patients. International Journal of Hyperthermia 36:1, pages 393-401.
Read now
Read now
Pei-Jian Peng, Hua Cheng, Xue-Qing Ou, Lin-Juan Zeng, Xuan Wu, Yu-Meng Liu, Zhong Lin, Yan-Na Tang, Si-Yang Wang, Hong-Yu Zhang & Zhi-Bin Chen. (2014) Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis. Drug Design, Development and Therapy 8, pages 1083-1087.
Read now
Read now
Yuji Miyamoto, Yasuo Sakamoto, Naoya Yoshida & Hideo Baba. (2014) Efficacy of S-1 in colorectal cancer. Expert Opinion on Pharmacotherapy 15:12, pages 1761-1770.
Read now
Read now
Taroh Satoh & Yuh Sakata. (2012) S-1 for the treatment of gastrointestinal cancer. Expert Opinion on Pharmacotherapy 13:13, pages 1943-1959.
Read now
Read now
Koh Miura, Tetsuhiko Shirasaka, Hiroki Yamaue & Iwao Sasaki. (2012) S-1 as a core anticancer fluoropyrimidine agent. Expert Opinion on Drug Delivery 9:3, pages 273-286.
Read now
Read now
Jing Wang, Yanchen Hu, Ling Li, Tongying Jiang, Siling Wang & Fengkui Mo. (2010) Indomethacin-5-fluorouracil-methyl ester dry emulsion: a potential oral delivery system for 5-fluorouracil. Drug Development and Industrial Pharmacy 36:6, pages 647-656.
Read now
Read now
R Pamela Mackenzie & A David McCollum. (2009) Novel agents for the treatment of adenocarcinoma of the pancreas. Expert Review of Anticancer Therapy 9:10, pages 1473-1485.
Read now
Read now
Articles from other publishers (57)
Chen Chang, Xiaofen Li, Ke Cheng, Zhaolun Cai, Junjie Xiong, Wanrui Lv, Ruizhen Li, Pei Zhang & Dan Cao. (2023) A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma. The Oncologist 28:7, pages e575-e584.
Crossref
Crossref
C.J.A. Punt, V. Heinemann, T. Maughan, C. Cremolini, E. Van Cutsem, R. McDermott, G. Bodoky, T. André, P. Osterlund, A.J. Teske & P. Pfeiffer. (2023) Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer. ESMO Open 8:2, pages 101199.
Crossref
Crossref
Dongdong Luo, Xiaochun Liu, Leilei Jiang, Zhikun Guo, Yan Lv, Xiaochen Tian, Xiaoyan Wang, Shuxiang Cui, Shengbiao Wan, Xianjun Qu, Ximing Xu & Xiaoyang Li. (2022) Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer. Journal of Medicinal Chemistry 65:21, pages 14553-14577.
Crossref
Crossref
Qianyu Wang, Xiaofei Shen, Gang Chen & Junfeng Du. (2022) Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers 14:12, pages 2928.
Crossref
Crossref
O. Mirallas, D. López-Valbuena, D. García-Illescas, C. Fabregat-Franco, H. Verdaguer, J. Tabernero & T. Macarulla. (2022) Advances in the systemic treatment of therapeutic approaches in biliary tract cancer. ESMO Open 7:3, pages 100503.
Crossref
Crossref
Seyed Parsa Eftekhar, Sohrab Kazemi & Ali Akbar Moghadamnia. (2022)
Effect of thymoquinone on pharmacokinetics of 5-fluorouracil in rats and its effect on human cell line
in vitro
. Human & Experimental Toxicology 41, pages 096032712211454.
Crossref
Crossref
Pawlos S. Tsegay, Daniela Hernandez, Christopher Brache, Chryssostomos Chatgilialoglu, Marios G. Krokidis, Prem Chapagain & Yuan Liu. (2022) Incorporation of 5’,8-cyclo-2’deoxyadenosines by DNA repair polymerases via base excision repair. DNA Repair 109, pages 103258.
Crossref
Crossref
Monish Karunakaran & Savio George Barreto. (2021) Surgery for pancreatic cancer: current controversies and challenges. Future Oncology 17:36, pages 5135-5162.
Crossref
Crossref
Jianfeng Guo, Zhuo Yu, Dandan Sun, Yifang Zou, Yun Liu & Leaf Huang. (2021) Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma. Molecular Cancer 20:1.
Crossref
Crossref
Chen Chang, Xiaofen Li & Dan Cao. (2021) Combination of gemcitabine, nab-paclitaxel, and S-1(GAS) as the first-line treatment for patients with locally advanced or advanced pancreatic ductal adenocarcinoma: study protocol for an open-label, single-arm phase I study. BMC Cancer 21:1.
Crossref
Crossref
Marco Massani, Luca Bonariol & Tommaso Stecca. (2021) Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review. Journal of Clinical Medicine 10:12, pages 2552.
Crossref
Crossref
Manali Haniti Mohd-Zahid, Siti Nadiah Zulkifli, Che Azurahanim Che Abdullah, JitKang Lim, Sharida Fakurazi, Kah Keng Wong, Andee Dzulkarnaen Zakaria, Norzila Ismail, Vuk Uskoković, Rohimah Mohamud & Iskandar Z. A. (2021) Gold nanoparticles conjugated with anti-CD133 monoclonal antibody and 5-fluorouracil chemotherapeutic agent as nanocarriers for cancer cell targeting. RSC Advances 11:26, pages 16131-16141.
Crossref
Crossref
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka & Veronika Vymetalkova. (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacology & Therapeutics 206, pages 107447.
Crossref
Crossref
Manali Haniti Mohd-Zahid, Rohimah Mohamud, Che Azurahanim Che Abdullah, JitKang Lim, Halima Alem, Wan Nurhidayah Wan Hanaffi & Iskandar Z. A.. (2020) Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles. RSC Advances 10:2, pages 973-985.
Crossref
Crossref
Takehiro Uemura, Tetsuya Oguri, Ken Maeno, Kazuki Sone, Akira Takeuchi, Satoshi Fukuda, Eiji Kunii, Osamu Takakuwa, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito & Akio Niimi. (2019) ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer. Cancer Chemotherapy and Pharmacology 84:6, pages 1229-1239.
Crossref
Crossref
Akhil Chawla & Cristina R. Ferrone. (2019) Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift. Frontiers in Oncology 9.
Crossref
Crossref
Li Song, Huajie Liu & Qiang Liu. (2019) Matrix metalloproteinase 1 promotes tumorigenesis and inhibits the sensitivity to 5-fluorouracil of nasopharyngeal carcinoma. Biomedicine & Pharmacotherapy 118, pages 109120.
Crossref
Crossref
R. Schierl, E. Fischer, G. Scherer, H.‐W. Hagedorn, Th. Göen & A. Hartwig. 2002. The MAK‐Collection for Occupational Health and Safety. The MAK‐Collection for Occupational Health and Safety
303
316
.
R. Schierl, E. Fischer, G. Scherer, H.‐W. Hagedorn, Th. Göen & A. Hartwig. 2002. The MAK‐Collection for Occupational Health and Safety. The MAK‐Collection for Occupational Health and Safety
337
352
.
Jariya Welbat, Pornthip Chaisawang, Wanassanun Pannangrong & Peter Wigmore. (2018) Neuroprotective Properties of Asiatic Acid against 5-Fluorouracil Chemotherapy in the Hippocampus in an Adult Rat Model. Nutrients 10:8, pages 1053.
Crossref
Crossref
Sheng Zhong, Shuai Qie, Liu Yang, Qi Yan, Linna Ge & Zhongfeng Wang. (2017) S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer. Medicine 96:30, pages e7611.
Crossref
Crossref
Seiichiro Mitani, Shigenori Kadowaki, Azusa Komori, Keiji Sugiyama, Yukiya Narita, Hiroya Taniguchi, Takashi Ura, Masashi Ando, Yozo Sato, Hidekazu Yamaura, Yoshitaka Inaba, Makoto Ishihara, Tsutomu Tanaka, Masahiro Tajika & Kei Muro. (2017) Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy. Medicine 96:22, pages e6874.
Crossref
Crossref
Jorge Hernando-Cubero, Ignacio Matos-García, Vicente Alonso-Orduña & Jaume Capdevila. (2017) The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed. Journal of Gastrointestinal Cancer 48:2, pages 135-147.
Crossref
Crossref
Pei-Jian Peng, Bao-Jun Lv, Zhi-Hui Wang, Hai Liao, Yu-Meng Liu, Zhong Lin, Yun-Yan Con & Pei-Yu Huang. (2016) Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens. Therapeutic Advances in Medical Oncology 9:2, pages 68-74.
Crossref
Crossref
Hao Li, Zheng-Yun Zhang, Zun-Qiang Zhou, Jiao Guan, Da-Nian Tong & Guang-Wen Zhou. (2016) Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial. Oncotarget 7:18, pages 26888-26897.
Crossref
Crossref
PeiJian Peng, XueQing Ou, Hai Liao, YuMeng Liu, SiYang Wang, ZhiBin Cheng & Zhong Lin. (2016) Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy. Therapeutic Advances in Medical Oncology 8:3, pages 153-159.
Crossref
Crossref
Daneng Li & Eileen M. O’Reilly. (2016) Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer. Surgical Oncology Clinics of North America 25:2, pages 311-326.
Crossref
Crossref
Trailokya Pandit & Philip A. Philip. 2016. Multimodality Management of Borderline Resectable Pancreatic Cancer. Multimodality Management of Borderline Resectable Pancreatic Cancer
159
168
.
Takahiro Kishi, Akira Nakamura, Satoshi Itasaka, Keiko Shibuya, Shigemi Matsumoto, Masashi Kanai, Yuzo Kodama, Kyoichi Takaori, Takashi Mizowaki & Masahiro Hiraoka. (2015) Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Pancreatology 15:6, pages 694-700.
Crossref
Crossref
Doudou Li, Changhao Chen, Yu Zhou, Rufu Chen, Xinxiang Fan, Zhuofei Bi, Zhihua Li & Yimin Liu. (2015) Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer. Medicine 94:35, pages e1345.
Crossref
Crossref
Jing Zhou, Rongce Zhao, Feng Wen, Pengfei Zhang, Ruilei Tang, Zedong Du, Xiaofeng He, Jian Zhang & Qiu Li. (2015) Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study. Medical Oncology 32:4.
Crossref
Crossref
Daneng Li & Eileen M. O’Reilly. (2015) Adjuvant and Neoadjuvant Systemic Therapy for Pancreas Adenocarcinoma. Seminars in Oncology 42:1, pages 134-143.
Crossref
Crossref
Fusun Ozmen, Tevfik Tolga Şahin & M. Mahir Ozmen. (2015) Current Adjuvant Therapeutic Approaches for Pancreatic Cancer. Advances in Therapy 32:1, pages 42-56.
Crossref
Crossref
Hee Man Kim, Kyong Joo Lee, Jihye Cha, Moon Jae Chung, Seungmin Bang, Jinsil Seong, Si Young Song & Seung Woo Park. (2014) A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer. Cancer Chemotherapy and Pharmacology 74:4, pages 861-865.
Crossref
Crossref
Qin Li, Han Yan, Wenting Liu, Hongchao Zhen, Yifan Yang & Bangwei Cao. (2014) Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials. PLoS ONE 9:8, pages e104346.
Crossref
Crossref
Yoshihiko Ooka, Tetsuhiro Chiba, Sadahisa Ogasawara, Kuniaki Arai, Eiichiro Suzuki, Akinobu Tawada, Tatsuya Yamashita, Fumihiko Kanai, Shuichi Kaneko & Osamu Yokosuka. (2014) A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma. Investigational New Drugs 32:4, pages 723-728.
Crossref
Crossref
Isha Rani, Kim Vaiphei & Navneet Agnihotri. (2014) Supplementation of fish oil augments efficacy and attenuates toxicity of 5-fluorouracil in 1,2-dimethylhydrazine dihydrochloride/dextran sulfate sodium-induced colon carcinogenesis. Cancer Chemotherapy and Pharmacology 74:2, pages 309-322.
Crossref
Crossref
Peter M. Wilson, Peter V. Danenberg, Patrick G. Johnston, Heinz-Josef Lenz & Robert D. Ladner. (2014) Standing the test of time: targeting thymidylate biosynthesis in cancer therapy. Nature Reviews Clinical Oncology 11:5, pages 282-298.
Crossref
Crossref
Hiroo Imai, Hiroshi Soeda, Keigo Komine, Kazunori Otsuka & Hiroyuki Shibata. (2013) Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer. BMC Palliative Care 12:1.
Crossref
Crossref
Hidenori Takahashi, Hiroaki Ohigashi, Kunihito Gotoh, Shigeru Marubashi, Terumasa Yamada, Masayuki Murata, Tatsuya Ioka, Hiroyuki Uehara, Masahiko Yano & Osamu Ishikawa. (2013) Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer. Annals of Surgery 258:6, pages 1040-1050.
Crossref
Crossref
Hideki UenoTatsuya IokaMasafumi IkedaShinichi OhkawaHiroaki YanagimotoNarikazu BokuAkira FukutomiKazuya SugimoriHideo BabaKenji YamaoTomotaka ShimamuraMasayuki ShoMasayuki KitanoAnn-Lii ChengKazuhiro MizumotoJen-Shi ChenJunji FuruseAkihiro FunakoshiTakashi HatoriTaketo YamaguchiShinichi EgawaAtsushi SatoYasuo OhashiTakuji OkusakaMasao Tanaka. (2013) Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study. Journal of Clinical Oncology 31:13, pages 1640-1648.
Crossref
Crossref
Zhi-xiang Zhuang, Hong Zhu, Ji Wang, Min-gao Zhu, Hui Wang, Wang-yang Pu, Hua-hui Bian, Lei Chen & Hong Zhang. (2013) Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients. Acta Pharmacologica Sinica 34:4, pages 570-580.
Crossref
Crossref
Eun Mi Lee, Yong Sang Hong, Kyu‐pyo Kim, Jae‐Lyun Lee, Sun Young Kim, Young Suk Park, Doo Ho Choi, Jong Hoon Kim, Seok‐Byung Lim, Chang Sik Yu, Jin Cheon Kim, Ju Hee Lee, Ah Young Kim & Tae Won Kim. (2012)
Phase
II
study of preoperative chemoradiation with S‐1 plus oxaliplatin in patients with locally advanced rectal cancer
. Cancer Science 104:1, pages 111-115.
Crossref
Crossref
M. Sabitha, N. Sanoj Rejinold, Amrita Nair, Vinoth-Kumar Lakshmanan, Shantikumar V. Nair & R. Jayakumar. (2013) Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydrate Polymers 91:1, pages 48-57.
Crossref
Crossref
YUICHIRO TADA, SHIN-ICHIRO MARUYA, TAKASHI SAOTOME, KOUKI MIURA, TATSUO MASUBUCHI, CHIHIRO FUSHIMI, ISAKU OKAMOTO, ETSURO TAKEISHI, SHUHEI YAMADA, HIROAKI ASAI & SHIN-ETSU KAMATA. (2012) Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma. Oncology Letters 4:5, pages 898-904.
Crossref
Crossref
Axel Grothey. (2012) S-1 in colorectal cancer: a new standard of care?. The Lancet Oncology 13:11, pages 1068-1070.
Crossref
Crossref
Yoshihito Ohtake, Tsutomu Sato, Takamitsu Kobayashi, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, Marina Yamaguchi, Kyoko Takami, Sang-Yong Yeu, Koo-Hyeon Ahn, Hiroharu Matsuoka, Kazumi Morikawa, Masayuki Suzuki, Hitoshi Hagita, Kazuharu Ozawa, Koji Yamaguchi, Motohiro Kato & Sachiya Ikeda. (2012)
Discovery of Tofogliflozin, a Novel
C
-Arylglucoside with an
O
-Spiroketal Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
. Journal of Medicinal Chemistry 55:17, pages 7828-7840.
Crossref
Crossref
Byung Woog Kang, Jong Gwang Kim, Yee Soo Chae, Yoo Jin Lee, Soo Jung Lee, Joon Ho Moon, Sang Kyun Sohn, Min Kyu Jung, Seong Woo Jeon, Yun-Jin Jang, Jongduk Seo, Yong Hyun Lee, Ohkyung Kwon, Ho Young Chung & Wansik Yu. (2011) Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer. Investigational New Drugs 30:4, pages 1671-1675.
Crossref
Crossref
Su Jin Lee, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Won Ki Kang, Jongtae Lee, Dong-Seok Yim & Ho Yeong Lim. (2011) Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. Investigational New Drugs 30:4, pages 1540-1547.
Crossref
Crossref
Masato Ozaka, Yuji Matsumura, Hiroshi Ishii, Yasushi Omuro, Takao Itoi, Hisatsugu Mouri, Keiji Hanada, Yasutoshi Kimura, Iruru Maetani, Yoshinobu Okabe, Masaji Tani, Takaaki Ikeda, Susumu Hijioka, Ryouhei Watanabe, Shinya Ohoka, Yuki Hirose, Masafumi Suyama, Naoto Egawa, Atsushi Sofuni, Takaaki Ikari & Toshifusa Nakajima. (2012) Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study). Cancer Chemotherapy and Pharmacology 69:5, pages 1197-1204.
Crossref
Crossref
H. Ueno, T. Okusaka, J. Furuse, K. Yamao, A. Funakoshi, N. Boku, S. Ohkawa, O. Yokosuka, K. Tanaka, F. Moriyasu, S. Nakamori & T. Sato. (2011) Multicenter Phase II Study of Gemcitabine and S-1 Combination Therapy (GS Therapy) in Patients With Metastatic Pancreatic Cancer. Japanese Journal of Clinical Oncology 41:8, pages 953-958.
Crossref
Crossref
Trung The Van, Masaki Hanibuchi, Soji Kakiuchi, Seidai Sato, Takuya Kuramoto, Hisatsugu Goto, Atsushi Mitsuhashi, Yasuhiko Nishioka, Shin-ichi Akiyama & Saburo Sone. (2010) The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice. Cancer Chemotherapy and Pharmacology 68:2, pages 497-504.
Crossref
Crossref
Mariela Blum, Akihiro Suzuki & Jaffer A Ajani. (2011) A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. Future Oncology 7:6, pages 715-726.
Crossref
Crossref
HIDEKI TOMIMOTO, MASAKI HANIBUCHI, FUMITAKA OGUSHI, YOSHIO OKANO, TSUTOMU SHINOHARA, HIROYUKI DOI, AKIYOSHI YAMAMOTO, EIJI TAKEUCHI, AKIHIKO YAMAMOTO, MASAHIKO AZUMA, HIROYA TADA, TAKANORI KANEMATSU, SOJI KAKIUCHI, HISATSUGU GOTO, SEIJI YANO, YASUHIKO NISHIOKA & SABURO SONE. (2011) A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer. Oncology Letters 2:3, pages 465-470.
Crossref
Crossref
Koh Miura, Makoto Kinouchi, Kazuyuki Ishida, Wataru Fujibuchi, Takeshi Naitoh, Hitoshi Ogawa, Toshinori Ando, Nobuki Yazaki, Kazuhiro Watanabe, Sho Haneda, Chikashi Shibata & Iwao Sasaki. (2010) 5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs. Cancers 2:3, pages 1717-1730.
Crossref
Crossref
Yasuo Ohashi, Toru Watanabe, Muneaki Sano, Hiroki Koyama, Hideo Inaji & Takaichiro Suzuki. (2009) Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial). Breast Cancer Research and Treatment 119:3, pages 633-641.
Crossref
Crossref
Kathryn M. Field & John R. Zalcberg. 2010. Rectal Cancer. Rectal Cancer
189
222
.